ArticleClinical and translational medicine2020

Pyrotinib combined with CDK4/6 inhibitor in HER2-positive metastatic gastric cancer: A promising strategy from AVATAR mouse to patients.

Zuhua Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.